Cargando…
The use of a surface active agent in the protection of a fusion protein during bioprocessing
The bioprocessing of a fusion protein is characterised by low yields and at a series of recovery and purification stages that leads to an overall 90% loss. Much of this apparent loss is due to the denaturation of a protein, missing a vital affinity ligand. However, there is evidence of the protectio...
Autores principales: | Blas, Peter, Tolner, Berend, Ward, John, Chester, Kerry, Hoare, Mike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334174/ https://www.ncbi.nlm.nih.gov/pubmed/30102764 http://dx.doi.org/10.1002/bit.26817 |
Ejemplares similares
-
IMAC capture of recombinant protein from unclarified mammalian cell feed streams
por: Kinna, Alexander, et al.
Publicado: (2015) -
Bioprocess microfluidics: applying microfluidic devices for bioprocessing
por: Marques, Marco PC, et al.
Publicado: (2017) -
Anti-HER2 imaging agents for breast cancer imaging
por: Tolner, B, et al.
Publicado: (2010) -
Bioprocess engineering : basic concepts /
por: Shuler, Michael L., 1947-
Publicado: (2002) -
Bioprocess engineering : basic concepts /
por: Shuler, Michael L., 1947-
Publicado: (2017)